Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 44.10M P/E 2.19 EPS this Y - Ern Qtrly Grth -
Income -4.83M Forward P/E 11.91 EPS next Y - 50D Avg Chg 3.00%
Sales 996k PEG - EPS past 5Y - 200D Avg Chg -12.00%
Dividend N/A Price/Book 1.30 EPS next 5Y 17.60% 52W High Chg -64.00%
Recommedations 3.00 Quick Ratio 1.40 Shares Outstanding 11.53M 52W Low Chg 28.00%
Insider Own 1.77% ROA -7.60% Shares Float 9.29M Beta 1.14
Inst Own 29.57% ROE -16.42% Shares Shorted/Prior 91.25K/113.38K Price 4.17
Gross Margin 100.00% Profit Margin - Avg. Volume 30,735 Target Price -
Oper. Margin -503.85% Earnings Date Nov 12 Volume 18,062 Change 1.46%
About TherapeuticsMD, Inc.

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

TXMD Chatroom

User Image ekraus Posted - 1 hour ago

$TXMD interesting about mayne buyout hard to think the txmd contract with mayne does not offer mayne the ability to cancel under certain circumstances note fielding buyout offers? does that mean there is an actual offer? magbe therre is

User Image vijalp9 Posted - 9 hours ago

$TXMD https://www.afr.com/street-talk/jefferies-fields-bidder-interest-for-376m-mayne-pharma-group-20241107-p5kotb Hard to imagine that a buyout of Mayne doesn’t include TXMD given how profitable their women’s health division has become. Also noticed a lot of attention to TXMD earn-out / royalty-related liabilities in the Mayne presentations — including their business update deck this morning. Buyers would want a clean balance sheet.

User Image ekraus Posted - 13 hours ago

$TXMD another bad day

User Image ekraus Posted - 1 day ago

$TXMD really bearish

User Image ekraus Posted - 1 day ago

$TXMD forgot to rate bearish

User Image ekraus Posted - 1 day ago

$TXMD Posting again look at long term chart not pretty

User Image ekraus Posted - 1 day ago

$TXMD woe is me the pain inflicted here hurts even though i owln zero shares i will post more oftn, i know you appreciate my input

User Image aless12 Posted - 2 days ago

$TXMD And ADCT

User Image aless12 Posted - 3 days ago

$TXMD Latest news weren’t positive ?

User Image hiTHit Posted - 6 days ago

$TXMD It would actually be a good company if it hadn't gone bankrupt.

User Image PenkeTrading Posted - 1 week ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of TherapeuticsMD Inc. Is that bullish or bearish? $TXMD #TherapeuticsMD #RsiOversold #NASDAQ

User Image aless12 Posted - 1 week ago

$TXMD buy

User Image alexanderswitzerland Posted - 1 week ago

$TXMD Analysts setting a target price of $5.00, indicating a potential upside of over 200%.  The company specializes in women’s health products, including FDA-approved therapies like BIJUVA and IMVEXXY, contributing to its revenue streams.  In the second quarter of 2024, TherapeuticsMD reported a net loss from continuing operations of $1.05 million, or $0.09 per share, an improvement from the $2.4 million loss in the same quarter of 2023.  The company’s strategic focus on expanding its market reach and product offerings positions it for future growth in the healthcare sector. Additionally, the stock’s current valuation presents an attractive entry point for investors seeking exposure to the women’s health market.

User Image Kobe2324 Posted - 1 week ago

$TXMD anyone have any opinions on most recent earnings?

User Image Estimize Posted - 1 week ago

$TXMD reported - EPS and - revenue for Q3. http://www.estimize.com/intro/txmd?chart=historical&metric_name=eps&utm_content=TXMD&utm_medium=

User Image hiTHit Posted - 1 week ago

$TXMD Don't worry, ours is the fastest hearse.

User Image aless12 Posted - 1 week ago

$OCGN $TXMD —> earning tomorrow $SYRS

User Image Kobe2324 Posted - 1 week ago

$TXMD crickets

User Image jfer333 Posted - 4 weeks ago

$TXMD we’re close I think … bought 3k more shares today. Sitting at 30k total now with a 1.85 avg. Got another 2k shares somewhere at a $35 average lmao

User Image hiTHit Posted - 1 month ago

$TXMD Losers regularly follow three stocks: The first is the stock they bought in the past and made a loss, the second is the stock they are currently making a loss on, and the third is the stock they will buy in the future and will definitely make a loss.

User Image brenbto Posted - 1 month ago

$TXMD tons of volume this morning???

User Image hiTHit Posted - 09/27/24

$TXMD We're bankrupt, we are closed forever.

User Image Stockweiller32 Posted - 09/26/24

@Sharmuda @arghhhh $TXMD they had a buyout offer of like 10$ a share but the fellas average was around 60$ they voted it down & next thing ya now tommy comes in on board, they all got screwed

User Image Stockweiller32 Posted - 09/26/24

@Sharmuda @arghhhh I’m not looking it up I’m done with DD on SRNE , but Tommy was on that board of lawyers that were in Texas , Tommy greased $TXMD

User Image Aigner_Andreas Posted - 2 months ago

#GoldenCross $TXMD at 6.42 R271 HiLo 16% T1Y 65 buy fwdPE -64.2 DIV N/A #Therapeuti #stocks #trading #finance #market

User Image ekraus Posted - 2 months ago

$TXMD mamy longs buried their money here what is different now?

User Image hiTHit Posted - 2 months ago

$TXMD There are more flowers in the hands of bankrupt companies than there are living companies.

User Image ekraus Posted - 2 months ago

$TXMD down 99.35% all time as of August z8 Sell

User Image paladinbst Posted - 08/30/24

$TXMD Have not followed TXMD in a long time. Dilution again took the price down here or other bad news?

User Image ngocnu Posted - 08/29/24

$TXMD

Analyst Ratings
Cantor Fitzgerald Neutral Aug 17, 23
Cantor Fitzgerald Neutral Jul 13, 22
HC Wainwright & Co. Neutral Jun 7, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Walker Marlan D Chief Executive Offi.. Chief Executive Officer Apr 12 Sell 3.65 1,170 4,270 12,307 04/14/23
Walker Marlan D Chief Executive Offi.. Chief Executive Officer Apr 12 Option 0 7,508 13,477 04/14/23
Donegan Michael C Prin. Fin. and Acctg.. Prin. Fin. and Acctg. Officer Apr 12 Option 0.00 50,000 61,853 04/14/23
Donegan Michael C Prin. Fin. and Acctg.. Prin. Fin. and Acctg. Officer Jan 26 Sell 5.08 1,697 8,621 11,853 01/30/23
Donegan Michael C Prin. Fin. and Acctg.. Prin. Fin. and Acctg. Officer Jan 26 Option 0 5,940 13,550 01/30/23
Donegan Michael C Prin. Fin. and Acctg.. Prin. Fin. and Acctg. Officer Jan 23 Sell 5.32 1,309 6,964 7,610 01/25/23
Donegan Michael C Prin. Fin. and Acctg.. Prin. Fin. and Acctg. Officer Jan 23 Option 0 4,365 8,919 01/25/23
Rubric Capital Management LP 10% Owner 10% Owner Dec 30 Sell 1333 29,000 38,657,000 01/03/23
Rubric Capital Management LP 10% Owner 10% Owner Dec 09 Buy 6.09 14,825 90,284 1,757,191 12/12/22
Bernick Brian Co-Chief Executive O.. Co-Chief Executive Officer Dec 06 Option 0 3,167 5,127 12/09/22
Bernick Brian Co-Chief Executive O.. Co-Chief Executive Officer Dec 06 Sell 5.62 1,255 7,053 3,872 12/09/22
Walker Marlan D General Counsel General Counsel Dec 06 Option 0 2,554 7,733 12/09/22
Walker Marlan D General Counsel General Counsel Dec 06 Sell 4.95 1,048 5,188 6,685 12/09/22
Glickman Mark A Co-Chief Executive O.. Co-Chief Executive Officer Dec 06 Sell 4.92 440 2,165 1,294 12/09/22
Glickman Mark A Co-Chief Executive O.. Co-Chief Executive Officer Dec 06 Option 0 1,734 1,734 12/09/22
Donegan Michael C Interim CFO/CAO/VP o.. Interim CFO/CAO/VP of Finance Dec 06 Option 0 3,476 5,464 12/09/22
Donegan Michael C Interim CFO/CAO/VP o.. Interim CFO/CAO/VP of Finance Dec 06 Sell 4.78 910 4,350 4,554 12/09/22
Rubric Capital Management LP 10% Owner 10% Owner Dec 07 Buy 5.75 20,413 117,375 1,742,366 12/09/22
Naughton Gail K Director Director Dec 07 Sell 5.2614 3,922 20,635 12/08/22
Rubric Capital Management LP 10% Owner 10% Owner Oct 28 Buy 1000 7,000 7,000,000 29,000 10/31/22
Rubric Capital Management LP 10% Owner 10% Owner Jul 29 Buy 413.47 580,000 239,812,600 15,000 08/01/22
Rubric Capital Management LP 10% Owner 10% Owner Jul 15 Buy 5.8 82,580 478,964 1,156,953 07/19/22
Donegan Michael C CAO and VP of Financ.. CAO and VP of Finance Nov 30 Sell 0.54 29,790 16,087 99,368 12/02/21
Collins Cooper C. Director Director Aug 19 Buy 0.75 1,000,000 750,000 1,236,864 08/19/21
DArecca James Chief Financial Offi.. Chief Financial Officer Aug 12 Sell 0.87 93,337 81,203 123,830 08/12/21
Donegan Michael C CAO and VP Finance CAO and VP Finance May 12 Sell 1.04 4,842 5,036 14,158 05/12/21
Milligan John C.K. IV Secretary/CEO of sub.. Secretary/CEO of subsidiary May 12 Sell 1.04 44,252 46,022 1,752,703 05/12/21
Finizio Robert G CEO CEO May 12 Sell 1.04 67,697 70,405 17,991,637 05/12/21